A phase 2 study of the toxin binding polymer tolevamer in patients with C. difficile associated diarrhoea

Trial Profile

A phase 2 study of the toxin binding polymer tolevamer in patients with C. difficile associated diarrhoea

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2018

At a glance

  • Drugs Tolevamer (Primary) ; Vancomycin
  • Indications Clostridium-difficile-infections; Diarrhoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2018 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top